The Vaccine Act of 1986 granted vaccine companies immunity from liability, significantly reducing their financial risks and incentivizing the production of new vaccines without the pressure of ensuring safety. No vaccine has undergone pre-licensing testing against a placebo-controlled group, raising concerns about the health outcomes of vaccinated versus unvaccinated children. Despite claims of misinformation, discussions with key health officials reveal a complex landscape of vaccine safety and regulatory oversight.
